| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | -0.17 | 1e-05 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.2 | 3e-05 |
| mRNA | selumetinib:UNC0638 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.15 | 9e-05 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.17 | 0.0001 |
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | -0.14 | 0.0001 |
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0003 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | 0.19 | 0.0003 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.16 | 0.0005 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0006 |